Skip to main content

Advertisement

Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats

Fig. 2

Left atrial cardiomyocyte mean cross-sectional area in the four study groups. a Control group; b diabetes mellitus (DM) group; c low-dose empagliflozin group; d high-dose empagliflozin group; e Illustrates cardiomyocyte cross-sectional area. Each group included 6–8 rats. *Compared with the control group, p < 0.05; **Compared with the DM group, p < 0.05

Back to article page